OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study
Alicia Alpuente, Anna de la Torre-Suñe, Edoardo Caronna, et al.
Cephalalgia (2023) Vol. 43, Iss. 8
Open Access | Times Cited: 12
Alicia Alpuente, Anna de la Torre-Suñe, Edoardo Caronna, et al.
Cephalalgia (2023) Vol. 43, Iss. 8
Open Access | Times Cited: 12
Showing 12 citing articles:
Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical resting-state connectivity in migraine patients
Edina Szabó, Nicolas R. Bolo, David Borsook, et al.
Cephalalgia (2025) Vol. 45, Iss. 2
Closed Access
Edina Szabó, Nicolas R. Bolo, David Borsook, et al.
Cephalalgia (2025) Vol. 45, Iss. 2
Closed Access
Efficacy of lasmiditan, rimegepant and ubrogepant for acute treatment of migraine in triptan insufficient responders: systematic review and network meta-analysis
Wattakorn Laohapiboolrattana, Priabprat Jansem, Prakit Anukoolwittaya, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Wattakorn Laohapiboolrattana, Priabprat Jansem, Prakit Anukoolwittaya, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study
Giorgio Dalla Volta, Antonio Russo, Marcello Silvestro, et al.
Cephalalgia (2024) Vol. 44, Iss. 11
Closed Access | Times Cited: 1
Giorgio Dalla Volta, Antonio Russo, Marcello Silvestro, et al.
Cephalalgia (2024) Vol. 44, Iss. 11
Closed Access | Times Cited: 1
Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years
Eduardo Pons-Fuster, O Lozano-Caballero, S Martín-Balbuena, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 6, pp. 1317-1326
Closed Access
Eduardo Pons-Fuster, O Lozano-Caballero, S Martín-Balbuena, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 6, pp. 1317-1326
Closed Access
Effects of levcromakalim in patients with migraine aura without headache: An experimental study
Andreas Vinther Thomsen, Mohammad Al‐Mahdi Al‐Karagholi, Anders Hougaard, et al.
Cephalalgia (2024) Vol. 44, Iss. 8
Closed Access
Andreas Vinther Thomsen, Mohammad Al‐Mahdi Al‐Karagholi, Anders Hougaard, et al.
Cephalalgia (2024) Vol. 44, Iss. 8
Closed Access
Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
Muneto Tatsumoto, Miki Ishida, Katsuhiro Iba, et al.
Headache The Journal of Head and Face Pain (2024)
Open Access
Muneto Tatsumoto, Miki Ishida, Katsuhiro Iba, et al.
Headache The Journal of Head and Face Pain (2024)
Open Access
Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody Is Effective for Preventing Migraine Aura Without Headache
Yasushi Shibata
Neurology International (2024) Vol. 16, Iss. 6, pp. 1279-1284
Open Access
Yasushi Shibata
Neurology International (2024) Vol. 16, Iss. 6, pp. 1279-1284
Open Access
(CGRP) Monocloncal antibodies
Claudia Altamura, Luigi Francesco Iannone, Luisa Fofi, et al.
Elsevier eBooks (2024), pp. 363-394
Closed Access
Claudia Altamura, Luigi Francesco Iannone, Luisa Fofi, et al.
Elsevier eBooks (2024), pp. 363-394
Closed Access
Calcitonin gene-related peptide (CGRP) and its role in migraine
Andrew S. Day, Jessica Ailani
Elsevier eBooks (2024), pp. 121-138
Closed Access
Andrew S. Day, Jessica Ailani
Elsevier eBooks (2024), pp. 121-138
Closed Access
Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule
Shiho Suzuki, Keisuke Suzuki, Tomohiko Shiina, et al.
Journal of the Neurological Sciences (2023) Vol. 455, pp. 122786-122786
Closed Access | Times Cited: 1
Shiho Suzuki, Keisuke Suzuki, Tomohiko Shiina, et al.
Journal of the Neurological Sciences (2023) Vol. 455, pp. 122786-122786
Closed Access | Times Cited: 1
Response to letter: “Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule” by Suzuki et al.
Keiko Ihara, Seiya Ohtani, Narumi Watanabe, et al.
Journal of the Neurological Sciences (2023) Vol. 455, pp. 122785-122785
Closed Access | Times Cited: 1
Keiko Ihara, Seiya Ohtani, Narumi Watanabe, et al.
Journal of the Neurological Sciences (2023) Vol. 455, pp. 122785-122785
Closed Access | Times Cited: 1
Neue Migränetherapeutika im Fokus
Hans‐Christoph Diener
InFo Neurologie + Psychiatrie (2023) Vol. 25, Iss. 7-8, pp. 22-23
Closed Access
Hans‐Christoph Diener
InFo Neurologie + Psychiatrie (2023) Vol. 25, Iss. 7-8, pp. 22-23
Closed Access
